T1	Disease	122	140	Alzheimer's disease	Explicit
T2	Disease	142	144	AD	Explicit
R1	Equiv	Arg1:T1	Arg2:T2
T3	Organism	54	59	human	Explicit
T4	OrganismPart	66	71	brain	Explicit
T5	OrganismPart	357	362	brain	Explicit
T6	OrganismPart	435	457	anterior hippocampal region	Explicit
T7	DiseaseTreatment	647	694	alpha-phosphorylated tau protein antibody	Explicit
T8	Staining	695	700	stained	Explicit
T9	CleavageAgent	1003	1010	Trypsin	Explicit
T10	AlkylationReagent	1177	1180	CAA	Explicit
T11	ReductionReagent	1160	1164	TCEP	Explicit
T12	FractionationMethod	1317	1356	C18 reverse-phase column	Explicit
T13	GradientTime	1572	1580	75 minutes	Explicit
T14	FlowRateChromatogram	1615	1630	0.35 ul/minute	Explicit
T15	Instrument	1745	1770	Thermo Orbitrap Fusion Lumos	Explicit
T16	IonizationType	1795	1818	electrospray ionization	Explicit
T17	AcquisitionMethod	1942	1944	DDA	Inferred
T18	MS2MassAnalyzer	1962	1986	Orbitrap Fusion Lumos	Inferred
T19	PrecursorMassTolerance	2010	2016	25ppm	Explicit
T20	FragmentMassTolerance	2050	2055	0.7 Th	Explicit
T21	CollisionEnergy	2075	2077	30	Explicit
T22	TechnologyType	2105	2131	mass spectrometry-based proteomics	Explicit
T23	Software	2155	2162	MaxQuant	Explicit
T24	SupplementaryFile	2415	2430	ProteomeXchange Consortium	Explicit
T25	SupplementaryFile	2432	2444	PRIDE repository	Explicit
R2	Equiv	Arg1:T24	Arg2:T25
T26	OrganismPart	2725	2732	BA21 region	Explicit
T27	OrganismPart	2734	2741	middle temporal lobe	Explicit
R3	Equiv	Arg1:T26	Arg2:T27
T28	Temperature	2765	2770	-80C	Explicit
T29	Temperature	2772	2777	-150C	Explicit
T30	Sex	2845	2850	gender	Explicit
T31	Age	2865	2868	age	Explicit
T32	Time	2882	2895	post-mortem delay	Explicit
T33	NumberOfBiologicalReplicates	2915	2917	3	Explicit
T34	NumberOfFractions	3102	3104	12	Explicit
T35	Modification	3225	3238	Carbamidomethyl	Explicit
A1	Modification	T35	fixed
T36	Modification	3356	3369	Citrullination	Explicit
A2	Modification	T36	variable
T37	Modification	3425	3440	Lysine carbamylation	Explicit
A3	Modification	T37	variable
